XML 56 R12.htm IDEA: XBRL DOCUMENT

Acquisitions and Divestitures	3 Months Ended
Acquisitions and Divestitures	Mar. 31, 2020
Business Combinations [Abstract]
Acquisitions and Divestitures	5. Acquisitions and Divestitures A. Acquisitions Other Acquisitions In the first quarter of 2020, we acquired the net assets of Ethos Diagnostic Science, a veterinary reference laboratory business with labs across the U.S. This transaction did not have a significant impact on our consolidated financial statements. During 2019, we completed the acquisitions of Platinum Performance, a nutrition-focused animal health business for companion animals and Phoenix Lab and ZNLabs, both full service veterinary reference laboratory companies with networks of labs across the U.S. These transactions did not have a significant impact on our consolidated financial statements. B. Divestitures During the three months ended March 31, 2020, we received cash proceeds of $20 million resulting from a payment received pursuant to an agreement related to the 2016 sale of certain U.S. manufacturing sites.